Locations
New Zealand · Auckland, New Zealand
Size
1 - 10 employees
Stage
Other
founded in
2016
NZeno is focused on supplying genetically edited pigs as a source of kidneys for human transplantation, addressing the critical shortage of human kidney donors. By utilizing advanced gene editing technology, NZeno produces safe pig kidneys that are compatible for human use, thereby restoring kidney function for patients suffering from end-stage renal disease. The company leverages New Zealand's high health status pigs, which have been recognized for their potential in xenotransplantation. With a strong foundation in biotechnology and a team experienced in human therapeutics, NZeno is positioned to make significant advancements in the field of organ transplantation.
Something looks off?